SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

NDRA

Endra Life Sciences Inc.
NASDAQHealth Care

Latest close: 4.74 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 17, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 14, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record50122 flagged findings
Reported transactions (Form 4)28since Jan 30, 2023 · and 4 other holdings
Corporate events (8-K)30since Dec 15, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-28share offering or dilution eventrecentOpen filing ↗
    “…Offering. The Company intends to use the net proceeds from the Offering for working capital and general corporate purposes, subject…”
    +1 more passage from the same document
    • “…intends to use the net proceeds from the Offering for working capital and general corporate purposes, subject to the restrictions in…”
  • 2026-05-28listing compliance noticerecentOpen filing ↗
    “…on Form 8-K filed with the SEC on May 30, 2025, on May 27, 2025, the Company received a notification letter from the Nasdaq…”
    +1 more passage from the same document
    • “…disclosed in a Current Report on Form 8-K filed with the SEC on May 30, 2025, on May 27, 2025, the Company received a…”
  • 2026-05-15capital return (buybacks/dividends)recentOpen filing ↗
    “…of the corporation will not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary…”
  • 2026-05-15bitcoin treasury exposurerecentOpen filing ↗
    “…valued based on the following inputs for the warrants: March 31, December 31, Input 2026 2025 Exercise Price $ 75.95 $ 6.32 and $…”
    +1 more passage from the same document
    • “…inputs for the warrants: March 31, December 31, Input 2026 2025 Exercise Price $ 75.95 $ 6.32 and $ 75.95 Stock Price $ 4.65 $ 4.53…”
  • 2026-05-15business pivot to crypto/bitcoinrecentOpen filing ↗
    “…Price $ 4.65 $ 4.53 and $ 7.41 Volatility 136.2 % and 159.9 % 140.44 % and 163.82 % Discount Rate 3.68 % and 3.83 % 3.47 % - 3.63…”
    +1 more passage from the same document
    • “…(Years) 0.89 and 3.39 1.13 and 5.01 Note 9 - Digital Assets The Company holds digital assets as part of its treasury strategy. As of…”
  • 2026-05-15share offering or dilution eventrecentOpen filing ↗
    “…ended March 31, 2026, the Company issued a total of 64,274 shares of its common stock under the October 2025 ATM Agreement (as…”
    +1 more passage from the same document
    • “…the October 2025 ATM Agreement (as defined below) in return for aggregate net proceeds of $ 263,748 , which takes into account $…”
  • 2026-05-15capital return (buybacks/dividends)recentOpen filing ↗
    “…considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit, and other…”
  • 2026-04-21listing compliance noticerecentOpen filing ↗
    “…of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company,…”
    +1 more passage from the same document
    • “…of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has…”

6 older entries not shown

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Apr 21, 2026).

Open the 8-K at the SEC

Reverse splits in 5 years

1 reverse split in 5 years (1:35 on Nov 7, 2024) · 1:35 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 501)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 8, 26Form 3 ↗Insider transaction
  • Oct 8, 26SCHEDULE 13D ↗Stake with intent to influence · ASP Isotopes Inc. · 15.1% · event on Oct 1, 26
  • Oct 2, 26S-4 ↗Merger, acquisition or tender offer
  • Oct 1, 26Form 425 ↗Merger, acquisition or tender offer
  • Oct 1, 268-K ↗Current report · Entered a material agreement
  • Sep 25, 26Form 425 ↗Merger, acquisition or tender offer
  • Sep 14, 26Form 425 ↗Merger, acquisition or tender offer
  • Sep 9, 26Form 425 ↗Merger, acquisition or tender offer
  • Sep 9, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 21, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 20, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 17, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 17, 268-K ↗Current report · Results
  • Aug 14, 2610-Q ↗Quarterly report
  • Aug 6, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 5, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 4, 26Form 425 ↗Merger, acquisition or tender offer
  • Jul 22, 26Form 425 ↗Merger, acquisition or tender offer
  • Jul 22, 26Form 425 ↗Merger, acquisition or tender offer
  • Jul 17, 26Form 425 ↗Merger, acquisition or tender offer
  • Jul 17, 26Form 425 ↗Merger, acquisition or tender offer
  • Jul 9, 268-K ↗Current report · Other events
  • Jun 29, 26SCHEDULE 13D/A ↗Stake with intent to influence · Anthony DiGiandomenico · 9.9% · event on Jun 25, 26 · amendment
  • Jun 26, 26Form 425 ↗Merger, acquisition or tender offer
  • Jun 26, 268-K ↗Current report · Entered a material agreement

501 filings on record, the oldest from Sep 2, 16.

Listing the 25 most recent filings of the 501 on record.

8-Ks, explained

Stress10Structure37Governance12
  • Structure3 material agreements entered2026show all 3hide
    • Oct 1, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
    • Jun 26, 26StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
    • May 28, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Apr 21, 26StressListing notice (8-K 3.01)nominal item 3.01: the filing covers another matter8-K 3.01 ↗
  • Mar 25, 26StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Dec 15, 25GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
  • Nov 28, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Oct 30, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Oct 15, 25StructureA material agreement was terminated+6 more in the same filing8-K/A 1.02 ↗
  • May 30, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Aug 13, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Aug 9, 24GovernanceA senior executive left or was appointed+4 more in the same filing8-K 5.02 ↗
  • Jul 17, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jun 6, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

11 older filings not shown · The record reaches back to May 12, 17.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • May 3, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jan 7, 22StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Aug 21, 20StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Apr 27, 20StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Aug 16, 19StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Aug 17, 18StressListing notice (8-K 3.01)8-K 3.01 ↗

The full record holds 10 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • ASP Isotopes Inc.15.1%Oct 1, 26SCHEDULE 13D ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Anthony DiGiandomenico9.9%Jun 25, 26SCHEDULE 13D/A ↗1 earlier filing

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • John Carter Lipman10.0%Oct 23, 25SCHEDULE 13G ↗
  • ATW Master Fund V LP9.9%Oct 16, 25SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • L1 Capital Global Opportunities Master Fund, Ltd.3.0%Nov 14, 25SCHEDULE 13G/A ↗1 earlier filing
  • S.H.N. Financial Investments Ltd.3.0%Nov 14, 25SCHEDULE 13G/A ↗

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Jun 25, Anthony DiGiandomenico filed notice of intent to sell up to $425K. That is about 5.23% of shares outstanding.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

The 90-day window closed with no sale of theirs on record in Form 4.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 27, 24Buy$2KUBS Group AG↗
  • Aug 27, 24Buyamount n/aUBS Group AG↗
  • May 18, 23Buy$25KMichael Milos ThorntonChief Technology Officer↗
  • May 2, 23Buy$100KANTHONY DIGIANDOMENICO↗
Stock compensation, tax and giftsshow the 11 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Mar 2, 26Compensationamount n/aRichard JacrouxChief Financial Officer↗
  • Mar 2, 26Compensationamount n/aAlexander Y TokmanChief Executive Officer↗
  • Jan 21, 26Compensationamount n/aAlexander Y TokmanChief Executive Officer↗
  • Jan 21, 26Compensationamount n/aLou Basenese↗
  • Jan 21, 26Compensationamount n/aRichard JacrouxChief Financial Officer↗
  • Jan 21, 26Compensationamount n/aMichael Harsh↗
  • Jan 21, 26Compensationamount n/aANTHONY DIGIANDOMENICO↗
  • Oct 10, 25Compensation$500KANTHONY DIGIANDOMENICO↗
  • Jun 11, 25Compensationamount n/aANTHONY DIGIANDOMENICO↗
  • Jun 11, 25Compensationamount n/aMichael Harsh↗
  • Jun 11, 25Compensationamount n/aLou Basenese↗

The full record holds 15 transactions and goes back to Jan 30, 23.

Its sector and its market

Endra Life Sciences Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Endra Life Sciences Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Endra Life Sciences Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
501 documents on file, from Sep 2, 2016 to Oct 8, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.